Ramnik Xavier, MD

Ramnik Xavier, MD

The overall goal in the laboratory is to discover and understand the functions of important mediators and effectors involved in innate and adaptive immunity. Of particular interest are cellular components and regulatory networks that interact dynamically within...
Deborah Wexler, MD, MsC

Deborah Wexler, MD, MsC

Through her research and mentorship, Dr. Wexler aims to define and achieve optimal treatment, quality of care, and quality of life for patients with type 2 diabetes using epidemiologic, clinical trial, and implementation science methodologies and through development...
Ramnik Xavier, MD

Miriam Udler, MD, PhD

Our team’s research aims to identify molecular subtypes of type 2 diabetes in order to improve patient management. We interrogate genetic data across the spectrum from rare to common variation to identify novel diabetes genes and mechanisms of disease. At the rare end...
Ramnik Xavier, MD

Anthony Rosenzweig, MD

Research in the Rosenzweig laboratory is focused identifying new mechanisms and targets in heart failure. Heart failure is closely related to metabolic dysregulation in general and diabetes in particular. In addition to studying what goes wrong in heart disease, a...
Eugene Rhee, MD

Eugene Rhee, MD

One of my lab’s major interests is the application of LC-MS based metabolomics to epidemiologic and physiologic studies of kidney disease, including diabetic nephropathy. We have spearheaded the first published studies of metabolomics to study the effects of the...